Prosecution Insights
Last updated: October 25, 2026

Confluence Genetics LLC

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Analysis

Confluence Genetics LLC has 2 pending office actions in Biotechnology & Pharmaceuticals. The actions involve 2 distinct examiners and 2 distinct art units, with no repeated assignment shown.

ROBINSON, HOPE A is the busiest examiner, with 1 pending action. Counsel should treat the matters independently while maintaining consistent technical terminology across the genetics portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
0
Medium (0%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROBINSON, HOPE A 1 67.7% +43.0%
KEOGH, MATTHEW R 1 78.5% +14.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18677865 Soybean Cultivar 3284306 KEOGH, MATTHEW R 26d overdue

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18677865 Soybean Cultivar 3284306 KEOGH, MATTHEW R 26d overdue
19334536 COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS ROBINSON, HOPE A —

Top Art Units

Art UnitApps
1652 1
1663 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19334536 COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS ROBINSON, HOPE A 1652 §112 Final Rejection — Pending Sep 19, 2025
18677865 Soybean Cultivar 3284306 KEOGH, MATTHEW R 1663 §102§112 Non-Final OA 26d overdue Pending May 29, 2024

Managing Confluence Genetics LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Confluence Genetics LLC have?

Confluence Genetics LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Confluence Genetics LLC applications?

Hope A Robinson has the most, with 1 of Confluence Genetics LLC's pending office actions.

What technology area are Confluence Genetics LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month